Tae Yeon Jeon

Prof. Dr. Tae Yeon Jeon

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in European Journal of Radiology
Verified
Journal Article
Closed access
JBJung Min Bae
Jung Min Bae
TJTae Yeon Jeon
Tae Yeon Jeon
JKJung Sun Kim
Jung Sun Kim
SKSeokhwi Kim
Seokhwi Kim
SHSook Min Hwang
Sook Min Hwang
JKJi Hye Kim
Ji Hye Kim

1 March 2014 in Clinical Radiology
Verified
Journal Article
Closed access
HYH.J. Yoon
H.J. Yoon
TJTae Yeon Jeon
Tae Yeon Jeon
SYS.-Y. Yoo
S.-Y. Yoo
JKJ.H. Kim
J.H. Kim
HEH. Eo
H. Eo
JKJ.S. Kim
J.S. Kim

1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
HKHae Won Kim
Hae Won Kim
SYSo-Young Yoo
So-Young Yoo
SOSaelin Oh
Saelin Oh
TJTae Yeon Jeon
Tae Yeon Jeon
JKJi Hye Kim
Ji Hye Kim
Kim HW, et al. Korean J Radiol. 2020 Jan;21:e16. https://doi.org/10.3348/kjr.2019.0343

23 October 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
SHSook Min Hwang
Sook Min Hwang
TJTae Yeon Jeon
Tae Yeon Jeon
SYSo-Young Yoo
So-Young Yoo
YCYon Ho Choe
Yon Ho Choe
SLSuk-Koo Lee
Suk-Koo Lee
JKJi Hye Kim
Ji Hye Kim

1 September 2015 in British Journal of Radiology
Verified
Journal Article
Closed access
TJTae Yeon Jeon
Tae Yeon Jeon
CKCHAN KYO KIM
CHAN KYO KIM
JKJ-H Kim
J-H Kim
GIG H Im
G H Im
Byung Kwan ParkByung Kwan Park
Byung Kwan Park
JLJ H Lee
J H Lee
Objective:To investigate the feasibility of dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DWI) in monitoring early therapeutic response to sorafenib in renal cell carcinoma (RCC) xenograft models.Methods:Sorafenib (40 mg kg−1) was administered orally to BALB/c nude mice (n = 9) bearing subcutaneous tumours of human RCC ACHN xenografts. DCE-MRI and DWI were obtained 0, 1, 3 and 7 days after therapy, and DCE-MRI parameters (Ktrans and ve) and apparent diffusion coefficient (ADC) values were calculated. Tumour size and volume changes were correlated with changes in DCE-MRI parameters or ADC values after therapy.Results:Following therapy, Ktrans showed a significant decrease over time (p = 0.005), whereas ve did not demonstrate significant changes between time points (p = 0.97). ADC values showed a progressive increase over time (p = 0.004). Compared with pre-therapy, Ktrans showed a significant decrease after 3 days of therapy (p = 0.039), and ADC values increased significantly after 7 ...

1 August 2017 in British Journal of Radiology
Verified
Journal Article
Closed access
SHSolbee Han
Solbee Han
TJTae Yeon Jeon
Tae Yeon Jeon
SHSook Min Hwang
Sook Min Hwang
SYSo-Young Yoo
So-Young Yoo
YCYon Ho Choe
Yon Ho Choe
JKJi Hye Kim
Ji Hye Kim
To compare the imaging findings using ultrasonography, MR cholangiopancreatography (MRCP), and intraoperative cholangiography (IOC) between Alagille syndrome (AGS) and biliary atresia (BA) in young infants with cholestatic jaundice. The institutional review board approved this retrospective study. Ultrasonography (n = 55), MRCP (n = 33), and IOC (n = 22) studies were performed in 55 infants (all younger than 3 months) with AGS (n = 7) and BA (n = 48). The ultrasound images were reviewed focusing on gallbladder (GB) abnormalities, triangular cord sign, hepatic artery enlargement and signs of portal hypertension. Visualization of the extrahepatic biliary tree was assessed by MRCP and IOC. Six (86%) AGS patients showed a small GB on ultrasound; this was comparable to that in BA patients (81%, 35/43). The images were negative for triangular cord sign and hepatic artery enlargement in all AGS patients, whereas they were positive in 48% (23/48) (p = 0.034) and 77% (33/43) (p < 0.001) of the BA patients, respectively. Signs of portal hypertension were less common in AGS patients than in BA patients (p = 0.010). Although non-visualization of the extrahepatic biliary tree by MRCP did not differ significantly between patients with AGS and BA, AGS patients showed a higher proportion of visible common bile ducts with IOC, compared to BA patients. The diagnosis of AGS was made in four infants (57%) before ultrasonography, based on extrahepatic manifestations. The small GB visualized on ultrasonography and non-visualization of extrahepatic biliary tree by MRCP commonly occurred in patients with either AGS or BA. However, triangular cord sign, hepatic artery enlargement and signs of portal hypertension onultrasonography and non-visualized common bile duct with IOC were less frequent in AGS patients than in BA patients. Advances in knowledge: Atypical imaging findings for BA should prompt a meticulous evaluation for the extrahepatic manifestations of AGS to avoid possibly harmful surgery.